HCW Biologics News - October 2026

HCW Biologics Gets FDA Roadmap for Cancer Drug — But Can a $25 Million Company Survive the Journey to the Clinic?
HCWB

HCW Biologics Gets FDA Roadmap for Cancer Drug — But Can a $25 Million Company Survive the Journey to the Clinic?

Shares of HCW Biologics surged 13% to $1.73 after the company disclosed that the FDA provided formal guidance on how to advance its lead cancer drug candidate...
HCWB

🟢 HCW Biologics is trading 13% up today after FDA guidance on cancer-study IND next steps

HCW Biologics is trading at $1.73 (+12.95%) after a recent FDA Type B meeting provided guidance on next steps for a first-in-human solid-tumor study. - The...